US · Healthcare · Medical Devices
EPS came in at -0.75 against a street estimate of -0.69 — a miss of 8.7%.
Analysts rate SINTX Technologies Inc a buy (1 buy, 1 hold, 0 sell out of 2) with an average price target of $9.12.
| Fund | Stake |
|---|---|
| Veracity Capital LLC | 1.21% |
| Geode Capital Management, LLC | 0.51% |
| Vanguard Fiduciary Trust Co | 0.37% |
| Vanguard Capital Management, LLC | 0.33% |
| XTX Topco Ltd | 0.27% |
| State Street Corp | 0.21% |
| DRW Securities, LLC | 0.19% |
| Virtus Wealth Solutions LLC | 0.16% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for SINTX Technologies Inc — free to start.
Google PlayApp StoreData updated 2026-09-18.